decisionhealth Newsletters, Answer Books - 2006 Issue 3 (March)
Program_Memos / 2000 / AB-00-83
Subscribe or sign in to view the full article.
Article Overview
This Program Memorandum from HCFA / DHHS addresses an update to prior guidance affecting ophthalmic drug and procedure billing. It explains the general scope of the payment change, the effective and implementation dates, and the associated coverage and billing context for carriers and intermediaries.
Why This Topic Matters
The article is relevant to billing staff, coders, and reimbursement teams that need to understand how this HCFA update affects claims handling for a specific drug and related eye procedures. It also helps readers track the timing of the policy change and the agencies involved.
What You Will Learn
- The purpose and scope of the HCFA Program Memorandum update
- The affected ophthalmic drug and procedure billing context
- The dates on which the memorandum became effective and was implemented
- The general carrier and intermediary implications of the guidance
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle teams
- Ophthalmology practice administrators
- Payers and claims processors
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com